PRVB - Provention Bio Inc's. (PRVB) CEO Ashleigh Palmer on Q4 2021 Results - Earnings Call Transcript
Provention Bio, Inc. (PRVB) Q4 2021 Earnings Conference Call February 24, 2022, 08:00 AM ET Company Participants Robert Doody - VP, IR Ashleigh Palmer - Co-Founder, President, CEO Francisco Leon - Co-Founder & Chief Scientific Officer Jason Hoitt - Chief Commercial Officer Thierry Chauche - Chief Financial Officer Conference Call Participants Gregory Renza - RBC Capital Markets Thomas Smith - SVB Leerink Justin Kim - Oppenheimer & Co. David Hoang - SMBC Alethia Young - Cantor Presentation Operator Good morning. My name is Irene, and I will be your conference operator for today. At this time, I would like to welcome everyone to the Provention Bio call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to Mr. Robert Doody, Vice President of Investor Relations for Provention Bio. Robert
For further details see:
Provention Bio, Inc's. (PRVB) CEO Ashleigh Palmer on Q4 2021 Results - Earnings Call Transcript